Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

The role of cognitive biases in short-term psychodynamic psychotherapy.

Kramer U, Ortega D, Ambresin G, Despland JN, de Roten Y.

Psychol Psychother. 2017 Sep 13. doi: 10.1111/papt.12152. [Epub ahead of print]

PMID:
28901694
2.

Efficacy of an adjunctive brief psychodynamic psychotherapy to usual inpatient treatment of depression: Results of a randomized controlled trial.

de Roten Y, Ambresin G, Herrera F, Fassassi S, Fournier N, Preisig M, Despland JN.

J Affect Disord. 2017 Feb;209:105-113. doi: 10.1016/j.jad.2016.11.013. Epub 2016 Nov 17.

PMID:
27894036
3.

What factors influence long-term antidepressant use in primary care? Findings from the Australian diamond cohort study.

Ambresin G, Palmer V, Densley K, Dowrick C, Gilchrist G, Gunn JM.

J Affect Disord. 2015 May 1;176:125-32. doi: 10.1016/j.jad.2015.01.055. Epub 2015 Feb 2.

PMID:
25704565
4.

How does addressing patient's defenses help to repair alliance ruptures in psychodynamic psychotherapy?: An exploratory study.

Gerostathos A, de Roten Y, Berney S, Despland JN, Ambresin G.

J Nerv Ment Dis. 2014 May;202(5):419-24. doi: 10.1097/NMD.0000000000000112.

PMID:
24727717
5.

Does agomelatine have a place in the treatment of depression?

Ambresin G, Gunn J.

BMJ. 2014 Mar 20;348:g2157. doi: 10.1136/bmj.g2157. No abstract available.

PMID:
24650658
6.

Self-rated health and long-term prognosis of depression.

Ambresin G, Chondros P, Dowrick C, Herrman H, Gunn JM.

Ann Fam Med. 2014 Jan-Feb;12(1):57-65. doi: 10.1370/afm.1562.

7.

A trajectory-based approach to understand the factors associated with persistent depressive symptoms in primary care.

Gunn J, Elliott P, Densley K, Middleton A, Ambresin G, Dowrick C, Herrman H, Hegarty K, Gilchrist G, Griffiths F.

J Affect Disord. 2013 Jun;148(2-3):338-46. doi: 10.1016/j.jad.2012.12.021. Epub 2013 Feb 1.

PMID:
23375580
8.

Efficacy of an adjunctive brief psychodynamic psychotherapy to usual inpatient treatment of depression: rationale and design of a randomized controlled trial.

Ambresin G, Despland JN, Preisig M, de Roten Y.

BMC Psychiatry. 2012 Oct 30;12:182. doi: 10.1186/1471-244X-12-182.

9.

[What place is there for psychotherapy in public psychiatry?].

Kramer U, Ambresin G, de Roten Y, Fassassi S, Hedjal A, Herrera F, Kolly S, Pomini V, Preisig M, Despland JN.

Rev Med Suisse. 2010 Sep 22;6(263):1760-2, 1764. French.

PMID:
20963958
10.

Olanzapine excretion into breast milk: a case report.

Ambresin G, Berney P, Schulz P, Bryois C.

J Clin Psychopharmacol. 2004 Feb;24(1):93-5. No abstract available.

PMID:
14709955
11.

[Schizophrenia, diabetes and new neuroleptics].

Ambresin G, Bryois Ch.

Praxis (Bern 1994). 2002 Dec 11;91(50):2181-92. Review. French.

PMID:
12520727

Supplemental Content

Loading ...
Support Center